Copyright Reports & Markets. All rights reserved.

Global Gene Therapy-based Drug Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Gene Therapy-based Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Viral Gene Delivery System
    • 1.2.3 Non-viral Gene Delivery System
  • 1.3 Market by Application
    • 1.3.1 Global Gene Therapy-based Drug Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Neurological Diseases
    • 1.3.3 Cancer
    • 1.3.4 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Gene Therapy-based Drug Market Perspective (2016-2027)
  • 2.2 Gene Therapy-based Drug Growth Trends by Regions
    • 2.2.1 Gene Therapy-based Drug Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Gene Therapy-based Drug Historic Market Share by Regions (2016-2021)
    • 2.2.3 Gene Therapy-based Drug Forecasted Market Size by Regions (2022-2027)
  • 2.3 Gene Therapy-based Drug Industry Dynamic
    • 2.3.1 Gene Therapy-based Drug Market Trends
    • 2.3.2 Gene Therapy-based Drug Market Drivers
    • 2.3.3 Gene Therapy-based Drug Market Challenges
    • 2.3.4 Gene Therapy-based Drug Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Gene Therapy-based Drug Players by Revenue
    • 3.1.1 Global Top Gene Therapy-based Drug Players by Revenue (2016-2021)
    • 3.1.2 Global Gene Therapy-based Drug Revenue Market Share by Players (2016-2021)
  • 3.2 Global Gene Therapy-based Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Gene Therapy-based Drug Revenue
  • 3.4 Global Gene Therapy-based Drug Market Concentration Ratio
    • 3.4.1 Global Gene Therapy-based Drug Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy-based Drug Revenue in 2020
  • 3.5 Gene Therapy-based Drug Key Players Head office and Area Served
  • 3.6 Key Players Gene Therapy-based Drug Product Solution and Service
  • 3.7 Date of Enter into Gene Therapy-based Drug Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapy-based Drug Breakdown Data by Type

  • 4.1 Global Gene Therapy-based Drug Historic Market Size by Type (2016-2021)
  • 4.2 Global Gene Therapy-based Drug Forecasted Market Size by Type (2022-2027)

5 Gene Therapy-based Drug Breakdown Data by Application

  • 5.1 Global Gene Therapy-based Drug Historic Market Size by Application (2016-2021)
  • 5.2 Global Gene Therapy-based Drug Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Gene Therapy-based Drug Market Size (2016-2027)
  • 6.2 North America Gene Therapy-based Drug Market Size by Type
    • 6.2.1 North America Gene Therapy-based Drug Market Size by Type (2016-2021)
    • 6.2.2 North America Gene Therapy-based Drug Market Size by Type (2022-2027)
    • 6.2.3 North America Gene Therapy-based Drug Market Size by Type (2016-2027)
  • 6.3 North America Gene Therapy-based Drug Market Size by Application
    • 6.3.1 North America Gene Therapy-based Drug Market Size by Application (2016-2021)
    • 6.3.2 North America Gene Therapy-based Drug Market Size by Application (2022-2027)
    • 6.3.3 North America Gene Therapy-based Drug Market Size by Application (2016-2027)
  • 6.4 North America Gene Therapy-based Drug Market Size by Country
    • 6.4.1 North America Gene Therapy-based Drug Market Size by Country (2016-2021)
    • 6.4.2 North America Gene Therapy-based Drug Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Gene Therapy-based Drug Market Size (2016-2027)
  • 7.2 Europe Gene Therapy-based Drug Market Size by Type
    • 7.2.1 Europe Gene Therapy-based Drug Market Size by Type (2016-2021)
    • 7.2.2 Europe Gene Therapy-based Drug Market Size by Type (2022-2027)
    • 7.2.3 Europe Gene Therapy-based Drug Market Size by Type (2016-2027)
  • 7.3 Europe Gene Therapy-based Drug Market Size by Application
    • 7.3.1 Europe Gene Therapy-based Drug Market Size by Application (2016-2021)
    • 7.3.2 Europe Gene Therapy-based Drug Market Size by Application (2022-2027)
    • 7.3.3 Europe Gene Therapy-based Drug Market Size by Application (2016-2027)
  • 7.4 Europe Gene Therapy-based Drug Market Size by Country
    • 7.4.1 Europe Gene Therapy-based Drug Market Size by Country (2016-2021)
    • 7.4.2 Europe Gene Therapy-based Drug Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Gene Therapy-based Drug Market Size (2016-2027)
  • 8.2 Asia-Pacific Gene Therapy-based Drug Market Size by Type
    • 8.2.1 Asia-Pacific Gene Therapy-based Drug Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Gene Therapy-based Drug Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Gene Therapy-based Drug Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Gene Therapy-based Drug Market Size by Application
    • 8.3.1 Asia-Pacific Gene Therapy-based Drug Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Gene Therapy-based Drug Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Gene Therapy-based Drug Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Gene Therapy-based Drug Market Size by Region
    • 8.4.1 Asia-Pacific Gene Therapy-based Drug Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Gene Therapy-based Drug Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Gene Therapy-based Drug Market Size (2016-2027)
  • 9.2 Latin America Gene Therapy-based Drug Market Size by Type
    • 9.2.1 Latin America Gene Therapy-based Drug Market Size by Type (2016-2021)
    • 9.2.2 Latin America Gene Therapy-based Drug Market Size by Type (2022-2027)
    • 9.2.3 Latin America Gene Therapy-based Drug Market Size by Type (2016-2027)
  • 9.3 Latin America Gene Therapy-based Drug Market Size by Application
    • 9.3.1 Latin America Gene Therapy-based Drug Market Size by Application (2016-2021)
    • 9.3.2 Latin America Gene Therapy-based Drug Market Size by Application (2022-2027)
    • 9.3.3 Latin America Gene Therapy-based Drug Market Size by Application (2016-2027)
  • 9.4 Latin America Gene Therapy-based Drug Market Size by Country
    • 9.4.1 Latin America Gene Therapy-based Drug Market Size by Country (2016-2021)
    • 9.4.2 Latin America Gene Therapy-based Drug Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Gene Therapy-based Drug Market Size (2016-2027)
  • 10.2 Middle East & Africa Gene Therapy-based Drug Market Size by Type
    • 10.2.1 Middle East & Africa Gene Therapy-based Drug Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Gene Therapy-based Drug Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Gene Therapy-based Drug Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Gene Therapy-based Drug Market Size by Application
    • 10.3.1 Middle East & Africa Gene Therapy-based Drug Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Gene Therapy-based Drug Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Gene Therapy-based Drug Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Gene Therapy-based Drug Market Size by Country
    • 10.4.1 Middle East & Africa Gene Therapy-based Drug Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Gene Therapy-based Drug Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Biogen
    • 11.1.1 Biogen Company Details
    • 11.1.2 Biogen Business Overview
    • 11.1.3 Biogen Gene Therapy-based Drug Introduction
    • 11.1.4 Biogen Revenue in Gene Therapy-based Drug Business (2016-2021)
    • 11.1.5 Biogen Recent Development
  • 11.2 Novartis
    • 11.2.1 Novartis Company Details
    • 11.2.2 Novartis Business Overview
    • 11.2.3 Novartis Gene Therapy-based Drug Introduction
    • 11.2.4 Novartis Revenue in Gene Therapy-based Drug Business (2016-2021)
    • 11.2.5 Novartis Recent Development
  • 11.3 Gilead Sciences
    • 11.3.1 Gilead Sciences Company Details
    • 11.3.2 Gilead Sciences Business Overview
    • 11.3.3 Gilead Sciences Gene Therapy-based Drug Introduction
    • 11.3.4 Gilead Sciences Revenue in Gene Therapy-based Drug Business (2016-2021)
    • 11.3.5 Gilead Sciences Recent Development
  • 11.4 Sarepta Therapeutics
    • 11.4.1 Sarepta Therapeutics Company Details
    • 11.4.2 Sarepta Therapeutics Business Overview
    • 11.4.3 Sarepta Therapeutics Gene Therapy-based Drug Introduction
    • 11.4.4 Sarepta Therapeutics Revenue in Gene Therapy-based Drug Business (2016-2021)
    • 11.4.5 Sarepta Therapeutics Recent Development
  • 11.5 Alnylam Pharmaceuticals
    • 11.5.1 Alnylam Pharmaceuticals Company Details
    • 11.5.2 Alnylam Pharmaceuticals Business Overview
    • 11.5.3 Alnylam Pharmaceuticals Gene Therapy-based Drug Introduction
    • 11.5.4 Alnylam Pharmaceuticals Revenue in Gene Therapy-based Drug Business (2016-2021)
    • 11.5.5 Alnylam Pharmaceuticals Recent Development
  • 11.6 Amgen
    • 11.6.1 Amgen Company Details
    • 11.6.2 Amgen Business Overview
    • 11.6.3 Amgen Gene Therapy-based Drug Introduction
    • 11.6.4 Amgen Revenue in Gene Therapy-based Drug Business (2016-2021)
    • 11.6.5 Amgen Recent Development
  • 11.7 Spark Therapeutics
    • 11.7.1 Spark Therapeutics Company Details
    • 11.7.2 Spark Therapeutics Business Overview
    • 11.7.3 Spark Therapeutics Gene Therapy-based Drug Introduction
    • 11.7.4 Spark Therapeutics Revenue in Gene Therapy-based Drug Business (2016-2021)
    • 11.7.5 Spark Therapeutics Recent Development
  • 11.8 Akcea Therapeutics
    • 11.8.1 Akcea Therapeutics Company Details
    • 11.8.2 Akcea Therapeutics Business Overview
    • 11.8.3 Akcea Therapeutics Gene Therapy-based Drug Introduction
    • 11.8.4 Akcea Therapeutics Revenue in Gene Therapy-based Drug Business (2016-2021)
    • 11.8.5 Akcea Therapeutics Recent Development
  • 11.9 bluebird bio
    • 11.9.1 bluebird bio Company Details
    • 11.9.2 bluebird bio Business Overview
    • 11.9.3 bluebird bio Gene Therapy-based Drug Introduction
    • 11.9.4 bluebird bio Revenue in Gene Therapy-based Drug Business (2016-2021)
    • 11.9.5 bluebird bio Recent Development
  • 11.10 Sunway Biotech
    • 11.10.1 Sunway Biotech Company Details
    • 11.10.2 Sunway Biotech Business Overview
    • 11.10.3 Sunway Biotech Gene Therapy-based Drug Introduction
    • 11.10.4 Sunway Biotech Revenue in Gene Therapy-based Drug Business (2016-2021)
    • 11.10.5 Sunway Biotech Recent Development
  • 11.11 SIBIONO
    • 11.11.1 SIBIONO Company Details
    • 11.11.2 SIBIONO Business Overview
    • 11.11.3 SIBIONO Gene Therapy-based Drug Introduction
    • 11.11.4 SIBIONO Revenue in Gene Therapy-based Drug Business (2016-2021)
    • 11.11.5 SIBIONO Recent Development
  • 11.12 AnGes
    • 11.12.1 AnGes Company Details
    • 11.12.2 AnGes Business Overview
    • 11.12.3 AnGes Gene Therapy-based Drug Introduction
    • 11.12.4 AnGes Revenue in Gene Therapy-based Drug Business (2016-2021)
    • 11.12.5 AnGes Recent Development
  • 11.13 Orchard Therapeutics
    • 11.13.1 Orchard Therapeutics Company Details
    • 11.13.2 Orchard Therapeutics Business Overview
    • 11.13.3 Orchard Therapeutics Gene Therapy-based Drug Introduction
    • 11.13.4 Orchard Therapeutics Revenue in Gene Therapy-based Drug Business (2016-2021)
    • 11.13.5 Orchard Therapeutics Recent Development
  • 11.14 Human Stem Cells Institute
    • 11.14.1 Human Stem Cells Institute Company Details
    • 11.14.2 Human Stem Cells Institute Business Overview
    • 11.14.3 Human Stem Cells Institute Gene Therapy-based Drug Introduction
    • 11.14.4 Human Stem Cells Institute Revenue in Gene Therapy-based Drug Business (2016-2021)
    • 11.14.5 Human Stem Cells Institute Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Gene Therapy-based Drug Scope and Market Size
    Gene Therapy-based Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene Therapy-based Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Viral Gene Delivery System
    Non-viral Gene Delivery System

    Segment by Application
    Neurological Diseases
    Cancer
    Other

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Biogen
    Novartis
    Gilead Sciences
    Sarepta Therapeutics
    Alnylam Pharmaceuticals
    Amgen
    Spark Therapeutics
    Akcea Therapeutics
    bluebird bio
    Sunway Biotech
    SIBIONO
    AnGes
    Orchard Therapeutics
    Human Stem Cells Institute

    Buy now